Global Neoantigen Targeted Therapies Industry Research Report 2020, Forecast to 2025

September 2020 | 106 pages | ID: GEB35A421FACEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Neoantigen Targeted Therapies market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Neoantigen Targeted Therapies is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Neoantigen Targeted Therapies industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Neoantigen Targeted Therapies by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Neoantigen Targeted Therapies market are discussed.

The market is segmented by types:

• Monotherapy
• Combination Therapy

It can be also divided by applications:

• Medical Research Institution
• Hospital and Clinic
• Other

And this report covers the historical situation, present status and the future prospects of the global Neoantigen Targeted Therapies market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Bavarian Nordic
• Neon Therapeutics
• Immunicum
• Genocea Biosciences
• MediGene
• Gradalis
• Iovance Biotherapeutics
• Immunovative Therapies

Report Includes:

• xx data tables and xx additional tables
• An overview of global Neoantigen Targeted Therapies market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Neoantigen Targeted Therapies market
• Profiles of major players in the industry, including Bavarian Nordic, Neon Therapeutics, Immunicum, Genocea Biosciences, MediGene.....

Research Objectives

• To study and analyze the global Neoantigen Targeted Therapies consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Neoantigen Targeted Therapies market by identifying its various subsegments.
• Focuses on the key global Neoantigen Targeted Therapies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Neoantigen Targeted Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Neoantigen Targeted Therapies submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Neoantigen Targeted Therapies Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Neoantigen Targeted Therapies Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 NEOANTIGEN TARGETED THERAPIES INDUSTRY OVERVIEW

2.1 Global Neoantigen Targeted Therapies Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Neoantigen Targeted Therapies Global Import Market Analysis
  2.1.2 Neoantigen Targeted Therapies Global Export Market Analysis
  2.1.3 Neoantigen Targeted Therapies Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Monotherapy
  2.2.2 Combination Therapy
2.3 Market Analysis by Application
  2.3.1 Medical Research Institution
  2.3.2 Hospital and Clinic
  2.3.3 Other
2.4 Global Neoantigen Targeted Therapies Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Neoantigen Targeted Therapies Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Neoantigen Targeted Therapies Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Neoantigen Targeted Therapies Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Neoantigen Targeted Therapies Manufacturer Market Share
  2.4.5 Top 10 Neoantigen Targeted Therapies Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Neoantigen Targeted Therapies Market
  2.4.7 Key Manufacturers Neoantigen Targeted Therapies Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Neoantigen Targeted Therapies Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Neoantigen Targeted Therapies Industry Impact
  2.7.1 How the Covid-19 is Affecting the Neoantigen Targeted Therapies Industry
  2.7.2 Neoantigen Targeted Therapies Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Neoantigen Targeted Therapies Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Neoantigen Targeted Therapies Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL NEOANTIGEN TARGETED THERAPIES MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Neoantigen Targeted Therapies Sales Market Share by Region
4.2 Global Neoantigen Targeted Therapies Revenue Market Share by Region (2015-2019)
4.3 Global Neoantigen Targeted Therapies Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Neoantigen Targeted Therapies Market Size Detail
  4.4.1 North America Neoantigen Targeted Therapies Sales Growth Rate (2015-2020)
  4.4.2 North America Neoantigen Targeted Therapies Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Neoantigen Targeted Therapies Market Size Detail
  4.5.1 Europe Neoantigen Targeted Therapies Sales Growth Rate (2015-2020)
  4.5.2 Europe Neoantigen Targeted Therapies Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Neoantigen Targeted Therapies Market Size Detail
  4.6.1 Japan Neoantigen Targeted Therapies Sales Growth Rate (2015-2020)
  4.6.2 Japan Neoantigen Targeted Therapies Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Neoantigen Targeted Therapies Market Size Detail
  4.7.1 China Neoantigen Targeted Therapies Sales Growth Rate (2015-2020)
  4.7.2 China Neoantigen Targeted Therapies Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL NEOANTIGEN TARGETED THERAPIES MARKET SEGMENT BY TYPE

5.1 Global Neoantigen Targeted Therapies Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Neoantigen Targeted Therapies Sales and Market Share by Type (2015-2020)
  5.1.2 Global Neoantigen Targeted Therapies Revenue and Market Share by Type (2015-2020)
5.2 Monotherapy Sales Growth Rate and Price
  5.2.1 Global Monotherapy Sales Growth Rate (2015-2020)
  5.2.2 Global Monotherapy Price (2015-2020)
5.3 Combination Therapy Sales Growth Rate and Price
  5.3.1 Global Combination Therapy Sales Growth Rate (2015-2020)
  5.3.2 Global Combination Therapy Price (2015-2020)

6 GLOBAL NEOANTIGEN TARGETED THERAPIES MARKET SEGMENT BY APPLICATION

6.1 Global Neoantigen Targeted TherapiesSales Market Share by Application (2015-2020)
6.2 Medical Research Institution Sales Growth Rate (2015-2020)
6.3 Hospital and Clinic Sales Growth Rate (2015-2020)
6.4 Other Sales Growth Rate (2015-2020)

7 GLOBAL NEOANTIGEN TARGETED THERAPIES MARKET FORECAST

7.1 Global Neoantigen Targeted Therapies Sales, Revenue Forecast
  7.1.1 Global Neoantigen Targeted Therapies Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Neoantigen Targeted Therapies Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Neoantigen Targeted Therapies Price and Trend Forecast (2020-2025)
7.2 Global Neoantigen Targeted Therapies Sales Forecast by Region (2020-2025)
  7.2.1 North America Neoantigen Targeted Therapies Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Neoantigen Targeted Therapies Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Neoantigen Targeted Therapies Production, Revenue Forecast (2020-2025)
  7.2.4 China Neoantigen Targeted Therapies Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF NEOANTIGEN TARGETED THERAPIES INDUSTRY KEY MANUFACTURERS

8.1 Bavarian Nordic
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Bavarian Nordic Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Bavarian Nordic News
8.2 Neon Therapeutics
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Neon Therapeutics Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Neon Therapeutics News
8.3 Immunicum
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Immunicum Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Immunicum News
8.4 Genocea Biosciences
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Genocea Biosciences Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Genocea Biosciences News
8.5 MediGene
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 MediGene Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 MediGene News
8.6 Gradalis
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Gradalis Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Gradalis News
8.7 Iovance Biotherapeutics
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Iovance Biotherapeutics News
8.8 Immunovative Therapies
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Immunovative Therapies Neoantigen Targeted Therapies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Immunovative Therapies News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neoantigen Targeted Therapies Picture
Figure Research Programs/Design for This Report
Figure Global Neoantigen Targeted Therapies Market by Regions (2019)
Table Global Market Neoantigen Targeted Therapies Comparison by Regions (M USD) 2019-2025
Table Global Neoantigen Targeted Therapies Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Neoantigen Targeted Therapies by Type in 2019
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global Neoantigen Targeted Therapies Sales by Application (2019-2025)
Figure Global Neoantigen Targeted Therapies Sales Market Share by Application in 2019
Figure Medical Research Institution Picture
Figure Hospital and Clinic Picture
Figure Other Picture
Table Global Neoantigen Targeted Therapies Sales by Manufacturer (2018-2020)
Figure Global Neoantigen Targeted Therapies Sales Market Share by Manufacturer in 2019
Table Global Neoantigen Targeted Therapies Revenue by Manufacturer (2018-2020)
Figure Global Neoantigen Targeted Therapies Revenue Market Share by Manufacturer in 2019
Table Global Neoantigen Targeted Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Neoantigen Targeted Therapies Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Neoantigen Targeted Therapies Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Neoantigen Targeted Therapies Market
Table Key Manufacturers Neoantigen Targeted Therapies Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neoantigen Targeted Therapies
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Neoantigen Targeted Therapies Sales (K Units) by Region (2015-2020)
Table Global Neoantigen Targeted Therapies Sales Market Share by Region (2015-2019)
Figure Global Neoantigen Targeted Therapies Sales Market Share by Region (2015-2019)
Figure Global Neoantigen Targeted Therapies Sales Market Share by Region in 2018
Table Global Neoantigen Targeted Therapies Revenue (Million US$) by Region (2015-2020)
Table Global Neoantigen Targeted Therapies Revenue Market Share by Region (2015-2020)
Figure Global Neoantigen Targeted Therapies Revenue Market Share by Region (2015-2020)
Figure Global Neoantigen Targeted Therapies Revenue Market Share by Region in 2019
Table Global Neoantigen Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Neoantigen Targeted Therapies Sales (K Units) Growth Rate (2015-2020)
Table North America Neoantigen Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Neoantigen Targeted Therapies Sales (K Units) Growth Rate (2015-2020)
Table Europe Neoantigen Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Neoantigen Targeted Therapies Sales (K Units) Growth Rate (2015-2020)
Table Japan Neoantigen Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Neoantigen Targeted Therapies Sales (K Units) Growth Rate (2015-2020)
Table China Neoantigen Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Neoantigen Targeted Therapies Sales by Type (2015-2020)
Table Global Neoantigen Targeted Therapies Sales Market Share by Type (2015-2020)
Figure Global Neoantigen Targeted Therapies Sales Market Share by Type in 2019
Table Global Neoantigen Targeted Therapies Revenue by Type (2015-2020)
Table Global Neoantigen Targeted Therapies Revenue Market Share by Type (2015-2020)
Figure Global Neoantigen Targeted Therapies Revenue Market Share by Type in 2019
Figure Global Monotherapy Sales Growth Rate (2015-2020)
Figure Global Monotherapy Price (2015-2020)
Figure Global Combination Therapy Sales Growth Rate (2015-2020)
Figure Global Combination Therapy Price (2015-2020)
Table Global Neoantigen Targeted Therapies Sales by Application (2015-2020)
Table Global Neoantigen Targeted Therapies Sales Market Share by Application (2015-2020)
Figure Global Neoantigen Targeted Therapies Sales Market Share by Application in 2019
Figure Global Medical Research Institution Sales Growth Rate (2015-2020)
Figure Global Hospital and Clinic Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Neoantigen Targeted Therapies Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Neoantigen Targeted Therapies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Neoantigen Targeted Therapies Price and Trend Forecast (2020-2025)
Table Global Neoantigen Targeted Therapies Sales (K Units) Forecast by Region (2020-2025)
Figure Global Neoantigen Targeted Therapies Production Market Share Forecast by Region (2020-2025)
Figure North America Neoantigen Targeted Therapies Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Neoantigen Targeted Therapies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Neoantigen Targeted Therapies Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Neoantigen Targeted Therapies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Neoantigen Targeted Therapies Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Neoantigen Targeted Therapies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Neoantigen Targeted Therapies Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Neoantigen Targeted Therapies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Bavarian Nordic Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Bavarian Nordic
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bavarian Nordic Neoantigen Targeted Therapies Market Share (2018-2020)
Table Bavarian Nordic Main Business
Table Bavarian Nordic Recent Development
Table Neon Therapeutics Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Neon Therapeutics
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Neon Therapeutics Neoantigen Targeted Therapies Market Share (2018-2020)
Table Neon Therapeutics Main Business
Table Neon Therapeutics Recent Development
Table Immunicum Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Immunicum
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Immunicum Neoantigen Targeted Therapies Market Share (2018-2020)
Table Immunicum Main Business
Table Immunicum Recent Development
Table Genocea Biosciences Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Genocea Biosciences
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genocea Biosciences Neoantigen Targeted Therapies Market Share (2018-2020)
Table Genocea Biosciences Main Business
Table Genocea Biosciences Recent Development
Table MediGene Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of MediGene
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure MediGene Neoantigen Targeted Therapies Market Share (2018-2020)
Table MediGene Main Business
Table MediGene Recent Development
Table Gradalis Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Gradalis
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Gradalis Neoantigen Targeted Therapies Market Share (2018-2020)
Table Gradalis Main Business
Table Gradalis Recent Development
Table Iovance Biotherapeutics Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Iovance Biotherapeutics
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Iovance Biotherapeutics Neoantigen Targeted Therapies Market Share (2018-2020)
Table Iovance Biotherapeutics Main Business
Table Iovance Biotherapeutics Recent Development
Table Immunovative Therapies Company Profile
Figure Neoantigen Targeted Therapies Product Picture and Specifications of Immunovative Therapies
Table Neoantigen Targeted Therapies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Immunovative Therapies Neoantigen Targeted Therapies Market Share (2018-2020)
Table Immunovative Therapies Main Business
Table Immunovative Therapies Recent Development
Table of Appendix